Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -51.50 | -18.04 | -4.38 | -5.82 | -33.58 | -31.31 |
PEG Ratio | 1.07 | 0.54 | -0.05 | -0.02 | 0.68 | -0.07 |
PS Ratio | 7.58 | 11.38 | 34.10 | 13.98 | 8.11 | n/a |
PB Ratio | 9.96 | 9.27 | 3.02 | 1.87 | 2.77 | 5.06 |
P/FCF Ratio | -153.35 | -24.61 | -4.84 | -7.29 | 146.26 | -38.90 |
P/OCF Ratio | -274.78 | -25.08 | -5.06 | -7.36 | 123.39 | -39.74 |
OCF/S Ratio | -2.76 | -45.38 | -673.43 | -189.92 | 6.57 | n/a |
Debt / Equity Ratio | 0.27 | 0.32 | 0.15 | 0.10 | 0.01 | 0.01 |
Quick Ratio | 3.82 | 4.39 | 6.85 | 14.61 | 15.33 | 31.68 |
Current Ratio | 3.85 | 4.42 | 6.93 | 14.61 | 15.33 | 31.68 |
Asset Turnover | 0.80 | 0.49 | 0.07 | 0.11 | 0.32 | n/a |
Interest Coverage | -7.94 | -16.19 | -44.39 | -30.38 | n/a | -143.53 |
Return on Equity | -19.34% | -51.46% | -68.99% | -32.19% | -8.29% | -16.15% |
Return on Assets | -11.81% | -30.65% | -51.19% | -27.25% | -7.73% | -15.59% |
Return on Invested Capital | -16.64% | -40.60% | -62.53% | -29.42% | -7.20% | -16.17% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 93.20% | 92.99% | 90.87% | 96.30% | 96.36% | n/a |
Net Profit Margin | -14.72% | -63.16% | -778.89% | -240.51% | -24.25% | n/a |
Pretax Profit Margin | -14.26% | -63.16% | -778.89% | -240.53% | -24.15% | n/a |
Operating Profit Margin | -15.72% | -65.90% | -820.53% | -242.92% | -21.32% | n/a |
FCF Margin | -4.94% | -46.24% | -704.96% | -191.88% | 5.54% | n/a |
EBITDA Margin | -11.88% | -58.20% | -754.69% | -231.27% | -23.60% | n/a |
Add to Watchlist
Select watchlists to add or remove TARS